85 results
8-K
EX-99.1
FENC
Fennec Pharmaceuticals Inc
25 Mar 24
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
4:05pm
2024, the FDA issued a public reminder to healthcare providers that PEDMARK (sodium thiosulfate injection) is not substitutable with other sodium
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
the Medicines and Healthcare Products Regulatory Agency of the United Kingdom, or any successor entity thereto.
“Minimum Purchase Quantity” has
424B7
FENC
Fennec Pharmaceuticals Inc
15 Mar 24
Prospectus with selling stockholder info
3:53pm
Petrichor Healthcare Capital Management LP to manage the investment program of Petrichor Opportunities Fund I LP. In that capacity, Petrichor Healthcare … for this beneficial owner is 220 East 42nd Street, 37th Floor, New York, NY 10017. By virtue of his control over Petrichor Healthcare Capital Management LP
8-K
s0w0em
2 Feb 24
FDA Issues Reminder of Non-Substitution of PEDMARKÒ (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
12:00am
8-K
EX-99.1
0l35y1m3vpmy7j
2 Feb 24
FDA Issues Reminder of Non-Substitution of PEDMARKÒ (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
12:00am
8-K
EX-99.1
8qmtq4ovrtwlsb2ip5l4
5 Dec 23
Fennec Announces Incremental $5 Million Investment from Petrichor
8:51pm
8-K
EX-99.1
6jy9vgjhaf5
6 Nov 23
Fennec Pharmaceuticals Announces Third Quarter 2023
7:38pm
8-K/A
EX-99.1
ruovuqc
7 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:51am
8-K
EX-99.1
9wg8rfsdet
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:58am
8-K
EX-99.1
zki2v541zvqn2rcg
4 Aug 23
Fennec Pharmaceuticals Announces Second Quarter 2023
10:57am
424B3
nl8tmz 2o
15 Dec 22
Prospectus supplement
5:12pm